PharmaMab Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Seed

  • Investors
  • 2

PharmaMab General Information

Description

Developer of therapeutic agents designed to fight cancer through monoclonal antibodies. The company's agents help to destroy malignant tumor cells and prevent their growth by blocking cell membrane receptors, enabling clinicians and doctors to help patients survive cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Via della Colonnetta, 50/A
  • 66100 Chieti
  • Italy
+39 0871
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Via della Colonnetta, 50/A
  • 66100 Chieti
  • Italy
+39 0871

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PharmaMab Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round Completed Pre-Clinical Trials
1. Grant Completed Pre-Clinical Trials
To view PharmaMab’s complete valuation and funding history, request access »

PharmaMab Patents

PharmaMab Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3880706-A1 Bispecific antibodies directed against human 90k and either endosialin or her3 Inactive 12-Nov-2018
WO-2020099235-A1 Bispecific antibodies directed against human 90k and either endosialin or her3 Inactive 12-Nov-2018

PharmaMab Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Invent (Rome) Venture Capital Minority
Ministero dell'Istruzione, dell'Università e della Ricerca (MIUR) Government
To view PharmaMab’s complete investors history, request access »

PharmaMab FAQs

  • When was PharmaMab founded?

    PharmaMab was founded in 2010.

  • Where is PharmaMab headquartered?

    PharmaMab is headquartered in Chieti, Italy.

  • What industry is PharmaMab in?

    PharmaMab’s primary industry is Drug Discovery.

  • Is PharmaMab a private or public company?

    PharmaMab is a Private company.

  • What is PharmaMab’s current revenue?

    The current revenue for PharmaMab is .

  • Who are PharmaMab’s investors?

    Invent (Rome) and Ministero dell'Istruzione, dell'Università e della Ricerca (MIUR) have invested in PharmaMab.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process